Allen, Greg M. http://orcid.org/0000-0002-0032-8140
Lim, Wendell A. http://orcid.org/0000-0003-4052-8056
Article History
Accepted: 9 August 2022
First Online: 29 September 2022
Competing interests
: W.A.L holds equity in Gilead and Intellia, is an adviser for Allogene Therapeutics and has filed patents related to this work. G.M.A. declares no competing interests.